Skip to content

Laparoscopic DA VINCI Robot Assisted Abdominal Wall Hernia Repair

Assistance Robotics for the Surgical Treatment of the Abdominal Wall Hernia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00908193
Acronym
ARTE
Enrollment
70
Registered
2009-05-25
Start date
2007-07-31
Completion date
2012-06-30
Last updated
2013-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Wall Hernia

Keywords

Treatment of abdominal ruptured, Digestive system disease, Coelioscopy, Assistance robotics, Medical device, DA VINCI Robot, Pain patient, Morphine consumption, Comparative Randomized study, patient over 18 years, with ruptured abdominal, with an indication of treatment of ruptured

Brief summary

The aim of this study is to prove the superiority of the robotic assistance in laparoscopic repair of abdominal wall hernias . In this monocentric randomized controlled trial, the use of the DA VINCI robot might reduce the post-operative pain of the patient resulting in a 40% reduction of morphine consumption.

Detailed description

Laparoscopic Robot Assisted abdominal wall hernia repair : a prospective randomized trial: The main judgement criterion is post operative pain reflected by morphine consumption during the first 48 hours. Secondary criteria are morbidity, quality of life, duration of surgery, conversion rate, complications, the the length of stay and hospital costs. In this single centre study, inclusion criteria are age above 18, no previous repair of the hernia with a mesh and a diameter of the parietal defect of less than 10 cm. Contraindications are chronic use of pain drugs of level II or above and renal insufficiency (clearance \<30ml/min). The robotic repair was described in a previous paper of our group and will be compared to our classical laparoscopic repair technique, and in both cases with the use of the same prosthetic mesh. A total of 70 patients to be included in an 18 months period was calculated to prove a 40% reduction in morphine consumption during the postoperative 48h (α=5% and β=10%). The total duration of the study is 30 months (12 months of follow-up for each patient).

Interventions

DEVICELaparoscopic DA VINCI Robot Assisted coelioscopy

Patients with abdominal wall hernia will be treated by robot-assisted coelioscopy for the poses of abdominal plate

PROCEDUREconventional coelioscopy

Patients with abdominal wall hernia will be treated by conventional coelioscopy for the poses of abdominal plate

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* over 18 years * with indication of hernia repair * a collar with a diameter of less than 10cm * no antecedent of hernia treatment with poses plate * agreeing coelioscopy * agreeing to participate the clinical study, having sign an informed consent * agreeing a regular monitor

Exclusion criteria

* taking analgesic tier 2 or 3 * against indication to anesthetics or coelioscopy * creatinine clearance less than 30 ml/min * pregnant woman and protected persons * no affiliation to social security * unable to understand the information form

Design outcomes

Primary

MeasureTime frame
Evaluate the reduction in morphine consumptionduring the postoperative 48h

Secondary

MeasureTime frame
Pain patient (ENS, total consumption of morphine)during the hospitalization, to 10 days,1 month, 6 months and 12 months of surgery
quality of life (questionary SF-36)1 month, 6 month and 12 month of surgery
length of stay in hospital, percentage return home to 24 hours of surgeryto 24 hours of surgery
morbidityduring the study
resumption of workafter surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026